chemXplore tracks 62 projects in Sweden, of which 27 are active.
Of the active ones, 20 new construction, 4 expansion, 2 revamp / retrofit and 1 conversion / repurposing.
6 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
EU clears first PD‑1 inhibitor plus ADC regimen for resectable muscle‑invasive bladder cancer regardless of cisplatin eligibility; phase 3 showed EFS HR 0.53 and OS HR 0.65.
Bolsters hydrometallurgy and solvent-extraction capabilities for recovery and purification of precious metals, rare earths and strategic materials; adds two applied research centres and specialist engineers.
EGM on 23 Nov 2026 in Stockholm; shareholders can attend in person, by proxy, or vote by post/BankID; record date 13 Nov and notice/postal-vote deadline 17 Nov.
106 aggregates sites and 44 hot‑mix asphalt plants change hands for ~SEK 5.5bn on a cash‑ and debt‑free basis; pro forma EBITDA multiple below buyer’s; deal subject to approval.
Combines upstream extraction with separation, heat‑transfer and downstream processing to offer end‑to‑end engineered solutions; phased integration completes by July 2027.
About 140 employees in Sweden expected to be affected; global scope and timing will depend on local consultations and legal requirements.
Revenues and output rose, but H1 earnings fell due to bio‑LNG market costs and abolition of double counting; secured 16 MW in EEG auction and plans €100m investment to expand biomethane conversion.
New rig tests pumps up to 25,000 m³/h and verifies up to MD900 full-scale; designed for larger sizes and expands Sala test and logistics capabilities.
Brings acquired specialty-pharma units into a single global management to pursue niche immunology, nephrology, transplant and infectious disease markets; targets ¥300bn by FY2030.
Luleå industrial park will recover phosphorus and rare earths from iron ore output to bolster European supply security; demo plant starts soon and ~500 jobs expected.
active / all projects
